Showing results (121-130 of 255) with videos related to
Sort By:
Pageof 26
Rheumatology (Oxford, England)|December 14, 2020
Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritisChristopher M Rooney, Kulveer Mankia, Suparna Mitra, et al.Diagnostic Microbiology and Infectious Disease|January 8, 2018
Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and EuropeDavid B Huang, Thomas M File, Matthew Dryden, et al.Journal of Clinical Microbiology|November 1, 2019
Hash-Based Core Genome Multilocus Sequence Typing for Clostridium difficileDavid W Eyre, Tim E A Peto, Derrick W Crook, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 25, 2023
A cost-utility analysis of two Clostridioides difficile infection guideline treatment pathwaysNicholas Swart, Araadhna M Sinha, Anthony Bentley, et al.The Journal of Antimicrobial Chemotherapy|January 22, 2020
Pharmacokinetic analysis of an extended-pulsed fidaxomicin regimen for the treatment of Clostridioides (Clostridium) difficile infection in patients aged 60 years and older in the EXTEND randomized controlled trialBenoit Guery, Areti Georgopali, Andreas Karas, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 30, 2016
Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013Kerrie A Davies, Helen Ashwin, Christopher M Longshaw, et al.Anaerobe|July 17, 2018
Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strainsLarry K Kociolek, Eric R Perdue, Warren N Fawley, et al.The Journal of Antimicrobial Chemotherapy|February 20, 2013
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implicationsSylvia B Debast, Martijn P Bauer, Ingrid M J G Sanders, et al.Future Microbiology|August 17, 2017
Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group reportMark H Wilcox, Natalia Dmitrieva, Ana Cristina Gales, et al.Advances in Experimental Medicine and Biology|January 4, 2024
European Practice for CDI TreatmentFidelma Fitzpatrick, Robert Brennan, Joffrey van Prehn, et al.Pageof 26